Cognitive and Behavioral Outcomes in Patients With Dementia With Lewy Bodies Treated With Nilotinib (S23.008)
To assess the safety, tolerability, and efficacy of nilotinib, and measure biomarkers in individuals with DLB.
Authors
- Barbara Wilmarth
- Charbel Moussa (ORCID: https://orcid.org/0000-0002-2012-7063)
- Giuseppe Esposito (ORCID: https://orcid.org/0000-0001-8080-8218)
- Fernando Pagán (ORCID: https://orcid.org/0000-0002-4052-156X)
- Yasar Torres‐Yaghi (ORCID: https://orcid.org/0000-0002-9676-3832)
- Raymond Scott Turner (ORCID: https://orcid.org/0000-0001-7534-2935)
Institutions
- Georgetown University (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000208439
- Primary Topic
- Medical and Pharmaceutic Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00